Highlights in GI cancer from ESMO WCGIC 2023

The ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 brought together world-renowned experts in oncology to present and discuss the latest advances in gastrointestinal cancer. In this podcast, we hear from leading healthcare professionals as they provide an overview of highlights from this year’s meeting. We will be joined by Philip Philip (Wayne State University School of Medicine/Henry Ford Health, Detroit, MI), Shouki Bazarbashi (King Faisal Specialist Hospital and Research Center-Riyadh, Riyadh, Saudi Arabia), and Anna Wagner (University of Lausanne, Lausanne, Switzerland).

We will hear on the feasibility of precision medicine approaches in pancreatic cancer, as well as findings from the INNOVATION trial, which assessed chemotherapy with trastuzumab and pertuzumab in patients HER2-positive gastric cancer. Several colorectal trials will additionally be discussed, including VELO, DEEPER, IMPROVE and AVETRIC, which all assessed the feasibility of panitumumab or cetuximab in the metastatic setting.

The post Highlights in GI cancer from ESMO WCGIC 2023 appeared first on VJOncology.